Aisling Capital Partners III LP

FollowCreate a free account to set a filing alert.

10% owner at Zeltiq Aesthetics Inc · on record since Oct 25, 2011
10% owner at Durata Therapeutics, Inc. · on record since Jul 25, 2012
10% owner at ASENSUS SURGICAL, INC. · on record since Sep 5, 2013
10% owner at Aravive, Inc. · on record since Mar 27, 2014
10% owner at AGILE THERAPEUTICS INC · on record since May 28, 2014
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at T2 Biosystems, Inc. · on record since Aug 14, 2014
Director at AGILE THERAPEUTICS INC · on record since Jan 27, 2015
Former 10% Owner at ASENSUS SURGICAL, INC. · on record since Feb 5, 2016
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016

Insider trading activity of Aisling Capital Partners III LP

Transactions on record: 15; since Nov 15, 2013

Purchases: 4; $13.5M

Sales: 1; $7M

Companies traded: 4; last filing Jan 12, 2017

Figures computed from official regulatory filings — .

Companies where Aisling Capital Partners III LP has traded

Loxo Oncology, Inc.1 tx · $5M · Jan 12, 2017
Aravive, Inc.12 tx · $3.8M · Jan 29, 2015
AGILE THERAPEUTICS INC1 tx · $4.8M · Jan 27, 2015
Zeltiq Aesthetics Inc1 tx · $7M · Nov 15, 2013

Track record of Aisling Capital Partners III LP

Insufficient history for a statistical track record (fewer than 5 purchases).

Transaction history of Aisling Capital Partners III LP

Co-insiders of Aisling Capital Partners III LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Loxo Oncology, Inc.Listing unverified	Jan 12, 2017	Buy	160,000	31.00 USD	$5M	conv 36First in 12mo	SEC
Aravive, Inc.Listing unverified	Jan 29, 2015	Buy	145,000	17.25 USD	$2.5M	conv 36Cluster	SEC
AGILE THERAPEUTICS INCListing unverified	Jan 27, 2015	Buy	811,966	5.85 USD	$4.8M	conv 48	SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-14,222,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-1,479,993	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	128,695	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-5,486,820	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Buy	60,000	21.00 USD	$1.3M	conv 48ClusterFirst in 12mo	SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	1,236,715	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-403,704	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	56,939	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	35,104	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	477,115	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-654,796	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Nov 15, 2013	Sell	-575,000	12.22 USD	$7M		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Loxo Oncology, Inc.Listing unverified	Jan 12, 2017	Buy	160,000	31.00 USD	$5M	conv 36First in 12mo	SEC
Aravive, Inc.Listing unverified	Jan 29, 2015	Buy	145,000	17.25 USD	$2.5M	conv 36Cluster	SEC
AGILE THERAPEUTICS INCListing unverified	Jan 27, 2015	Buy	811,966	5.85 USD	$4.8M	conv 48	SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-14,222,222	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-1,479,993	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	128,695	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-5,486,820	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Buy	60,000	21.00 USD	$1.3M	conv 48ClusterFirst in 12mo	SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	1,236,715	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-403,704	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	56,939	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	35,104	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	Other	477,115	—	n/a (No price was disclosed in the filing)		SEC
Aravive, Inc.Listing unverified	Mar 27, 2014	OtherD (derivative)	-654,796	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Zeltiq Aesthetics IncListing unverified	Nov 15, 2013	Sell	-575,000	12.22 USD	$7M		SEC